| （単位：千ドル） | 1Q21 | 2Q21 | 3Q21 | 1Q22 | 2Q22 | 3Q22 | 1Q23 | 2Q23 | 3Q23 | 1Q24 | 2Q24 | 3Q24 | 1Q25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 研究開発費 | 10,423 | 14,850 | 16,553 | 16,923 | 20,711 | 19,839 | 21,697 | 30,960 | 28,400 | 18,852 | 16,198 | 16,395 | 12,355 |
| 営業費用 | 18,797 | 30,710 | 23,695 | 24,346 | 29,055 | 26,179 | 28,930 | 37,201 | 35,020 | 24,457 | 21,972 | 22,270 | 17,614 |
| 営業利益 | -18,797 | -30,460 | -23,695 | -24,346 | -29,055 | -26,179 | -28,930 | -37,201 | -35,020 | -24,457 | -21,972 | -11,270 | -17,614 |
| 純利益 | -18,701 | -30,381 | -22,930 | -24,254 | -28,906 | -25,779 | -27,460 | -35,752 | -33,325 | -23,234 | -21,072 | -10,586 | -15,334 |
| 一株あたり利益 | - | - | - | - | -0.77 | -0.69 | -0.58 | -0.75 | -0.7 | -0.48 | -0.44 | -0.22 | -0.26 |
| 希薄化後一株あたり利益 | - | - | - | - | -0.77 | -0.69 | -0.58 | -0.75 | -0.7 | -0.48 | -0.44 | -0.22 | -0.26 |
| EBITDA | - | - | - | - | - | - | - | - |